About Rexer Pharma
Rexer Pharma is a company based in Hyderabad (India) founded in 1996. It operates as a B2B and Export. The company has 16 employees as of March 31, 2023. Rexer Pharma offers products and services including Ampirex 250, Ciprex-250, Diclorex, Hazer-20, and Recobal. Rexer Pharma operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Hyderabad, India
- Employees 16 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Rexer Pharma Private Limited
- Date of Incorporation 20 Dec, 1996
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$333 K (USD)8.09as on Mar 31, 2023
-
Net Profit
$1.19 K (USD)53.15as on Mar 31, 2023
-
EBITDA
$35.16 K (USD)162.02as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
16
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rexer Pharma
Rexer Pharma offers a comprehensive portfolio of products and services, including Ampirex 250, Ciprex-250, Diclorex, Hazer-20, and Recobal.
Antibiotic formulation for treating bacterial infections effectively.
Antibiotic drug used for infection control and prevention.
Anti-inflammatory medication for pain relief and inflammation reduction.
Drug for gastrointestinal issues and symptom management.
Supplement for nerve health and rejuvenation support.
Funding Insights of Rexer Pharma
Detailed funding history for Rexer Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rexer Pharma
Investment portfolio details for Rexer Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rexer Pharma
Detailed financials for Rexer Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rexer Pharma Comparisons
Peer comparison for Rexer Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rexer Pharma
Rexer Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Rexer Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rexer Pharma
Complete news archive for Rexer Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rexer Pharma
Rexer Pharma was founded in 1996.
Rexer Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at Rexer Pharma is 16.
Annual revenue of Rexer Pharma is $333K as on Mar 31, 2023.
Rexer Pharma is a pharmaceutical company that produces and exports a wide range of formulations, including antibiotics, anti-inflammatory drugs, and hormonal injectables. They operate through manufacturing processes focused on quality and product development, supplying to global markets. Based in Hyderabad, India, they serve as exporters and suppliers, meeting industry standards for generics and specialty products while emphasizing affordable healthcare solutions.
Rexer Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Rexer Pharma offers Ampirex 250, Ciprex-250, Diclorex, Hazer-20, and Recobal.